Jul 1, 2012
By:
William Looney
Mastery of the clinical trial process has become essential to positioning new therapies for leadership in an increasingly crowded—and lengthy—race to registration.
|
Jul 1, 2012
By:
William Looney
In a wake up call to this year's Emerging Leaders a group of St. Joseph's Business School Health Management alumni say time has no limit on surprises—change for pharma is here and its good.
|
Jul 1, 2012
By:
William Looney
Pharm Exec's 2012 roster of Emerging Leaders—our sixth to date—is not only a way to recognize a few individuals who've made a difference in their organizations. It also serves as a barometer to track larger changes in the workplace.
|
|
Jun 1, 2012
By:
William Looney
As the old Broadway song goes, June is busting out all over—and true to the season this month's issue stretches the seams with content that ranges from the sublime to the ridiculous.
|
|
Jun 1, 2012
By:
William Looney
Pharm Exec convened a panel of heavy hitters in business development to crack the bat on best practices in licensing and M&A for the year ahead.
|
|
May 1, 2012
By:
William Looney
The industry's reputation as a growth industry no one wants to pay for is more secure than ever, writes Pharm Exec Editor William Looney.
|
May 1, 2012
By:
William Looney
Data has become as important as the drug in driving success in healthcare.
|
|
Apr 24, 2012
By:
William Looney
Broaden your industry exposure. Think beyond yourself... Timely advice from this year's HBA Woman of the Year, Carolyn Buck Luce.
|
|
Apr 4, 2012
By:
William Looney
IP must adapt to new ways of extracting value from assets the industry never knew it had, writes William Looney.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
